Artiaga, Bianca L.
Morozov, Igor
Ransburgh, Russell
Kwon, Taeyong
Balaraman, Velmurugan
Indran, Sabarish V.
De Carvalho Madrid, Darling Melany
Gu, Weihong
Henningson, Jamie
Ma, Wenjun
Richt, Jürgen A.
Driver, John P.
Funding for this research was provided by:
National Institute of Child Health and Human Development (HD092286, HD092286)
National Institute of Food and Agriculture (2016-09448)
National Institute of Allergy and Infectious Diseases (HHSN272201400006C)
U.S. Department of Homeland Security (DHS-2010-ST-061-AG0001)
Article History
Received: 22 May 2022
Accepted: 13 July 2022
First Online: 1 August 2022
Declarations
:
: These studies were carried out in accordance with Kansas State University's Institutional Animal Care and Use Committee (IACUC) approved protocols under the project number 4067 approved on 04/17/2018, and Institutional Biosafety Committee (IBC) registration document number 1284 approved on 03/21/2018. As well as all relevant local, state, and federal regulations and policies.
: Not applicable.
: The authors declare no conflict of interest in the present study. The funding sources had no part in study design and conceptualization, collection, analysis, or interpretation of data, writing the manuscript, or in the decision to publish results. The JAR laboratory received support from Tonix Pharmaceuticals, Genus plc, Xing Technologies and Zoetis, outside of the reported work. JAR is inventor on patents and patent applications on the use of antivirals and vaccines for the treatment and prevention of virus infections, owned by Kansas State University, KS. Author Jürgen A. Richt was not involved in the journal’s review or decisions related to this manuscript.